The main aims of this study are, for a UK population, to characterise the prevalence and extent of myocardial involvement from COVID-19 infection, to assess recovery status at 6 months, and to understand the impact on patient quality of life and functional capacity. As part of the COVID-HEART protocol, there is a blood biomarker and genetic sub-study which participants will have the option of participating in alongside the main study.
- 0116 204 4786
University of Leicester
Glenfield General Hospital
Last Updated: 17/02/2021
|Year||Access Requests Received||Access Requests Approved|